These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 23274885)

  • 1. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
    Kmoch S; Stránecký V; Emes RD; Mitchison HM
    Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
    Warrier V; Vieira M; Mole SE
    Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCL disease mechanisms.
    Palmer DN; Barry LA; Tyynelä J; Cooper JD
    Biochim Biophys Acta; 2013 Nov; 1832(11):1882-93. PubMed ID: 23707513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuronal ceroid-lipofuscinoses: a historical introduction.
    Haltia M; Goebel HH
    Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses.
    Butz ES; Chandrachud U; Mole SE; Cotman SL
    Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165571. PubMed ID: 31678159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of the NCLs -- status and perspectives.
    Siintola E; Lehesjoki AE; Mole SE
    Biochim Biophys Acta; 2006 Oct; 1762(10):857-64. PubMed ID: 16828266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards understanding the neuronal ceroid lipofuscinoses.
    Kohlschütter A; Schulz A
    Brain Dev; 2009 Aug; 31(7):499-502. PubMed ID: 19195801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
    Miller JN; Kovács AD; Pearce DA
    Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients.
    Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN
    Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of the neuronal ceroid lipofuscinoses (Batten disease).
    Mole SE; Cotman SL
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2237-41. PubMed ID: 26026925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
    Bond M; Holthaus SM; Tammen I; Tear G; Russell C
    Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile neuronal ceroid lipofuscinosis and education.
    von Tetzchner S; Fosse P; Elmerskog B
    Biochim Biophys Acta; 2013 Nov; 1832(11):1894-905. PubMed ID: 23470553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.
    Mole SE; Williams RE; Goebel HH
    Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel missense mutation in CLN8 in late infantile neuronal ceroid lipofuscinosis: The first report of a CLN8 mutation in Japan.
    Katata Y; Uematsu M; Sato H; Suzuki S; Nakayama T; Kubota Y; Kobayashi T; Hino-Fukuyo N; Saitsu H; Kure S
    Brain Dev; 2016 Mar; 38(3):341-5. PubMed ID: 26443629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.
    Hirz M; Drögemüller M; Schänzer A; Jagannathan V; Dietschi E; Goebel HH; Hecht W; Laubner S; Schmidt MJ; Steffen F; Hilbe M; Köhler K; Drögemüller C; Herden C
    Mol Genet Metab; 2017 Mar; 120(3):269-277. PubMed ID: 28024876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.